United States Drug Enforcement Administration Executive and Leadership Team

Frank Kalder, the Chief Financial Officer at United States Drug Enforcement Administration, manages the agency's fiscal operations and financial strategy. Overseeing all aspects of budgeting, financial planning, and resource allocation, Kalder ensures that funds are utilized effectively to support the enforcement of controlled substances laws. This critical role involves developing financial models that sustain the agency's complex investigations and international operations. By directing financial reporting and compliance, Frank Kalder upholds the highest standards of fiscal responsibility. The position requires meticulous attention to detail in managing expenditures related to combating drug manufacturing and distribution networks. Kalder's financial acumen directly supports the agency's ability to bring organizations involved in illicit drug traffic to the criminal and civil justice system, ensuring operational continuity and strategic financial health.

Esther Chege, the Chief Operating Officer at United States Drug Enforcement Administration, directs the agency's day-to-day operational activities and internal processes. Overseeing the implementation of strategies designed to reduce the availability of illicit controlled substances, Chege ensures seamless coordination between various operational units. This leadership function involves optimizing resource deployment for investigations into drug manufacturing and distribution. By managing critical infrastructure and support services, Esther Chege enhances the agency's capacity to execute its mandate across domestic and international markets. The role demands a comprehensive understanding of operational logistics and risk management within the context of enforcing controlled substances laws. Chege's operational leadership is vital for bringing organizations involved in illicit drug traffic to justice and supporting non-enforcement programs.

Gary Owen, the Associate Administrator and Chief Operating Officer for Business Operations at United States Drug Enforcement Administration, spearheads the strategic direction and execution of all business operations. Overseeing critical functions such as human resources, information technology, and procurement, Owen ensures the agency possesses the necessary resources and infrastructure to enforce controlled substances laws effectively. This multifaceted role involves driving efficiency and innovation across administrative and support departments, directly impacting the agency's ability to combat illicit drug manufacturing and distribution. By managing the business operations framework, Gary Owen supports the successful prosecution of organizations involved in drug trafficking. Owen's leadership ensures that the agency's operational capacity is robust, enabling comprehensive engagement with both domestic and international efforts to reduce the availability of illicit substances.

Marc Kuzmicki, the Chief of Staff at United States Drug Enforcement Administration, directs strategic initiatives and operational alignment across the organization. Overseeing critical staff functions, Kuzmicki ensures the efficient execution of the agency's mandate to enforce controlled substances laws. This leadership position involves coordinating inter-agency communications and supporting the development of policies that combat illicit drug manufacturing and distribution. By managing key administrative processes, Marc Kuzmicki facilitates the agency's engagement with domestic and international partners. The role demands a deep understanding of the complex legal and operational landscape governing controlled substances, ensuring all activities directly support the agency's mission to bring organizations involved in drug trafficking to justice. Kuzmicki's oversight extends to critical support services that enable field operations and policy implementation, thereby reinforcing the agency's impact on reducing illicit drug availability.